Literature DB >> 10328555

Pharmacological effects in mice of anandamide and its related fatty acid ethanolamides, and enhancement of cataleptogenic effect of anandamide by phenylmethylsulfonyl fluoride.

K Watanabe1, T Matsunaga, S Nakamura, T Kimura, I K Ho, H Yoshimura, I Yamamoto.   

Abstract

Anandamide (N-arachidonoylethanolamine) and six fatty acid ethanolamides were synthesized and their pharmacological effects in mice were assessed using catalepsy, hypothermia and pentobarbital-induced sleep prolongation as indices. The effects of phenylmethylsulfonyl fluoride (PMSF) pretreatment on anandamide effects were also evaluated and discussed in relation to inhibition of anandamide amidohydrolase in mouse brain and liver. The cataleptogenic effect of anandamide (ED50=6.0 mg/kg, i.v.) was 4 to 6 times more active than those of N-oleoyl- (ED50=26.5 mg/kg, i.v.) and N-linoleoylethanolamine (ED50=37.5 mg/kg, i.v.), although the peak time in the effect was observed within 1 min after i.v. administration. None of the saturated fatty acid ethanolamides (N-myristoyl-, N-palmitoyl-, N-stearoyl- and N-arachidoylethanolamine) showed a positive response in the cataleptogenic effect even at a dose up to 40 mg/kg i.v. Anandamide, N-linoleoyl-, N-oleoyl- and N-myristoylethanolamine (10 mg/kg, i.v.) produced a significant hypothermia (0.19 to 0.59 degrees C) at 5 to 15 min after administration. The duration of the effects of these ethanolamides was also relatively short. Anandamide, N-linoleoyl-, N-oleoyl- and N-palmitoylethanolamine (5 or 10 mg/kg, i.v.) significantly prolonged pentobarbital-induced sleeping time by 148-207% of control sleeping time. The cataleptogenic effect of anandamide was markedly potentiated by pretreatment of mice with PMSF (100 mg/kg, i.p.). The ED50 (mg/kg, i.v.) of anandamide was 0.48 (0.24-0.96) in PMSF-pretreated mice. The pretreatment of mice with PMSF significantly decreased the metabolic clearance rate of anandamide in microsomal fractions of liver and brain. Thus, the Vmax/Km values of brain and hepatic microsomes were 26 and 10%, respectively, as compared with those of control mice. The present study demonstrated that anandamide and N-acylethanolamines of unsaturated fatty acids exhibited cannabinoid-like effects in mice, and that anandamide amidohydrolase has an important role in the pharmacological effects of anandamide in vivo.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10328555     DOI: 10.1248/bpb.22.366

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  9 in total

1.  Thermoregulatory phenotype of the Trpv1 knockout mouse: thermoeffector dysbalance with hyperkinesis.

Authors:  Andras Garami; Eszter Pakai; Daniela L Oliveira; Alexandre A Steiner; Samuel P Wanner; M Camila Almeida; Vladimir A Lesnikov; Narender R Gavva; Andrej A Romanovsky
Journal:  J Neurosci       Date:  2011-02-02       Impact factor: 6.167

Review 2.  Fatty acid amide signaling molecules.

Authors:  Cyrine Ezzili; Katerina Otrubova; Dale L Boger
Journal:  Bioorg Med Chem Lett       Date:  2010-08-13       Impact factor: 2.823

3.  N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo.

Authors:  T Bisogno; D Melck; N M Gretskaya; V V Bezuglov; L De Petrocellis; V Di Marzo
Journal:  Biochem J       Date:  2000-11-01       Impact factor: 3.857

4.  Metabolomic Analysis of Coronary Heart Disease in an African American Cohort From the Jackson Heart Study.

Authors:  Daniel E Cruz; Usman A Tahir; Jie Hu; Debby Ngo; Zsu-Zsu Chen; Jeremy M Robbins; Daniel Katz; Raji Balasubramanian; Bennet Peterson; Shuliang Deng; Mark D Benson; Xu Shi; Lucas Dailey; Yan Gao; Adolfo Correa; Thomas J Wang; Clary B Clish; Kathryn M Rexrode; James G Wilson; Robert E Gerszten
Journal:  JAMA Cardiol       Date:  2022-02-01       Impact factor: 30.154

5.  Long-term consequences of perinatal fatty acid amino hydrolase inhibition.

Authors:  Chia-Shan Wu; Daniel Morgan; Chris P Jew; Chris Haskins; Mary-Jeanette Andrews; Emma Leishman; Corinne M Spencer; Traci Czyzyk; Heather Bradshaw; Ken Mackie; Hui-Chen Lu
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

Review 6.  The transient receptor potential vanilloid-1 channel in thermoregulation: a thermosensor it is not.

Authors:  Andrej A Romanovsky; Maria C Almeida; Andras Garami; Alexandre A Steiner; Mark H Norman; Shaun F Morrison; Kazuhiro Nakamura; Jeffrey J Burmeister; Tatiane B Nucci
Journal:  Pharmacol Rev       Date:  2009-09-11       Impact factor: 25.468

7.  Contributions of different modes of TRPV1 activation to TRPV1 antagonist-induced hyperthermia.

Authors:  Andras Garami; Yury P Shimansky; Eszter Pakai; Daniela L Oliveira; Narender R Gavva; Andrej A Romanovsky
Journal:  J Neurosci       Date:  2010-01-27       Impact factor: 6.167

Review 8.  Effects of Cannabinoid Agonists and Antagonists on Sleep in Laboratory Animals.

Authors:  Maureen L Petrunich-Rutherford; Michael W Calik
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  GPR55, a G-protein coupled receptor for lysophosphatidylinositol, plays a role in motor coordination.

Authors:  Chia-Shan Wu; Hongmei Chen; Hao Sun; Jie Zhu; Chris P Jew; James Wager-Miller; Alex Straiker; Corinne Spencer; Heather Bradshaw; Ken Mackie; Hui-Chen Lu
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.